Get 15% OFF for TargetMol inhibitors

March-April promotion : TargetMol small molecule inhibitors

TargetMol has evolved into one of the biggest global compound library and small molecule suppliers. It offers over 120 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies for laboratory and scientific use.

Small molecule inhibitors have become important tool drugs in life science research in recent years due to their significant advantages in the regulation of different cellular processes, ranging from cell cycle control and mitosis to signaling pathways and gene expression; and from migration and wound healing, to apoptosis and autophagy.

Small molecule inhibitors have many advantages:

Can be easily manipulated and can be applied to a variety of cell or animal experiments
Good permeability to cross cell membranes easily;
Higher stability

You can now benefit 15% off on All TragetMol inhibitors, the offer valid up to April 15 th.

Order Now

Best selling inhibitors for hot signaling pathways

Angiogenesis	MAPK	PI3K/Akt/mTOR signaling
Cell Cycle/Checkpoint	Microbiology / Virology	NF-kb
DNA Damage/DNA Repair	Stem Cells	Proteases/Proteasome
GPCR/G Protein	Apoptosis	Ubiquitination

You might also be interested in the following signaling pathways

Oxidation-reduction	Metabolism	Autophagy
Tyrosine Kinase/Adaptors	Chromatin/Epigenetic	Cytoskeletal Signaling
Neuroscience	Endocrinology/Hormones	Enzyme
Membrane transporter/Ion channel	Immunology / Inflammation	JAK/STAT signaling

Check out high-quality publications using TargetMol inhibitors

Publications name	Catalogue Number	Impact factor
Nature,Wang J, Liu Y, Liu Y, et al. 2019 May;569(7757):509-513."Time-resolved protein activation by proximal decaging in living systems[J]. "	T4006	43.07
Nature, 2019: 1-5. Peng G, Suo S, Cui G, et al. "Molecular architecture of lineage allocation and tissue organization in early mouse embryo[J]."	T3112	43.07
Nature, 2020: 1-6. Lu X Y, Shi X J, Hu A, et al. "Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis[J]. "		42.778
Cell, 2020: Wang Q, Wu J, Wang H, et al. "Structural basis for RNA replication by the SARS-CoV-2 polymerase[J]. "	T7222	36.216
Cell, 2019: 179(4): 864-879. e19. Fan K, Li Y, Wang H, et al. "Stress-Induced Metabolic Disorder in Peripheral CD4+ T Cells Leads to Anxiety-like Behavior[J]. "	T6119	36.216
Nature medicine, 2018 Dec: 24(12):1919-1929. Sun L, Xie C, Wang G, et al. "Gut microbiota and intestinal FXR mediate the clinical benefits of metformin[J]."	T0847	32.621
Cell, 2021: Zhuang Y, Xu P, Mao C, et al. "Structural insights into the human D1 and D2 dopamine receptor signaling complexes[J]. "	T5842	30.165
Cancer Discovery, 2020: Espinet E, Gu Z, Imbusch C D, et al. "Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell-of-origin[J]."		29.497
Nature genetics, 2018 Dec: 50(12):1666-1673. Zhang X, Jia S, Chen Z, et al. "Cilia-driven cerebrospinal fluid flow directs expression of urotensin neuropeptides to straighten the vertebrate body axis[J]. "	L1500	27.125
Cancer Cell, 2020, 38(1): 115-128. e9. Tang Y, Fang G, Guo F, et al. "Selective Inhibition of STRN3-Containing PP2A Phosphatase Restores Hippo Tumor-Suppressor Activity in Gastric Cancer[J]."	T3112	26.602
Cancer Cell, 2020 Bhatt S, Pioso M S, Olesinski E A, et al. "Reduced Mitochondrial Apoptotic Priming Drives Resistance to BH3 Mimetics in Acute Myeloid Leukemia[J]."	T6007	26.602
Cancer Cell, 2020 Li C, Sun Y D, Yu G Y, et al. "Integrated Omics of Metastatic Colorectal Cancer[J]. "	T2303	26.602
Cell stem cell, 2018 Apr 22(4): 529-542. e5. Cao Shangtao, Shengyong Yu, Dongwei Li, Jing Ye, Xuejie Yang, Chen Li, Xiaoshan Wang et al. "Chromatin accessibility dynamics during chemical induction of pluripotency[J]."	T1788	23.29
Cell stem cell, 2018 Apr 22(4): 529-542. e5. Cao Shangtao, Shengyong Yu, Dongwei Li, Jing Ye, Xuejie Yang, Chen Li, Xiaoshan Wang et al. "Chromatin accessibility dynamics during chemical induction of pluripotency[J]."	T1963	23.29

Need an answer now?

Give us a call

Leave a message, we'll get back to you

Contact us

Follow us

Leave a message

Meetings

Create your mytebu-bio account and benefit from

Get 15% OFF for TargetMol inhibitors

March-April promotion : TargetMol small molecule inhibitors

Best selling inhibitors for hot signaling pathways

You might also be interested in the following signaling pathways

Check out high-quality publications using TargetMol inhibitors

Want to know more publications?